Table 1 Comparison of baseline demographic and laboratory data with 3-Month Follow-Up data for each studied group in H pylori positive patients.

Age (Independent t test)

Mean ± SD

53.46 ± 11.55

53.02 ± 10.27

0.841

Range

30–79

34–77

Sex, N (%) (Chi square)

Male

27(54)

27(54)

1

Female

23(46)

23(46)

BMI

27(26–29)

22–36

27(25–30)

22–36

0.275

27(26–28)

24–33

27(26–28)

24–34

0.276

SBP

130(120–135)

110–155

130(120–135)

100–150

0.478

130(125–135)

120–170

130(125–135)

120–150

0.394

DBP

80(70–85)

60–100

80(70–90)

60–100

0.541

75(70–80)

70–110

80(75–90)

60–100

0.312

creatinine

1.7(1.5–1.8)

1.3–2.3

1.6(1.4–1.8)

1.2–2.3

< 0.001

1.7(1.6–1.8)

1.5–1.9

1.7(1.6–1.8)

1.4–1.9

0.288

Total protein

7(6.8–7.2)

5.9–7.9

7(6.9–7.1)

6–7.7.7

0.752

7(6.9–7.3)

6.2–8.2

7(7–7.2.2)

6.4–8.4

0.74

Albumin

4.1(3.9–4.3)

3.5–4.9

4(4–4.2.2)

3.4–4.9

0.934

4(3.8–4.1)

3.3–4.7

4(3.9–4.1)

3.3–4.8

0.099

ACR

1188(800–1369)

600–2735

819.5(512–987)

237–1951

< 0.001

1120(877–1333)

600–3345

984(785–1211)

314–3211

< 0.001

FBS

129(122–143)

100–198

122.5(113–130)

100–143

< 0.001

140(125–166)

120–199

133.5(125–154)

113–177

0.006

2hpp Blood sugar

165.5(145–189)

56–276

145.5(130–160)

34–201

< 0.001

168.5(155–211)

133–297

158.5(144–176)

124–220

< 0.001

HbA1c

7.2(7.1–7.5)

6.5–8.3

7.1(7–7.3.3)

6.5–7.9

< 0.001

7.1(7–7.5.5)

6.5–8.3

7.1(7–7.3.3)

6.4–8.4

0.032

GFR

42.5(38–47)

31–63

44.5(39–51)

30–82

< 0.001

43.5(35–50)

30–62

43.5(37–50)

31–66

0.482

Response to treatment: Stool H. pylori antigen after eradication therapy

Negative N (%)

36(72)

28(56)

0.096

Positive N (%)

14(28)

22(44)